Arch Biopartners Inc. ACHFF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -22.28% | 12.54% | 28.07% | 63.49% | 11.92% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 119.36% | 827.41% | 25.51% | -108.69% | 326.12% |
| Change in Net Operating Assets | -- | -- | -- | -- | -- |
| Cash from Operations | 4.32% | 60.75% | 44.26% | 34.52% | 36.21% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -63.85% | -76.72% | -82.04% | 43.10% | -70.29% |
| Total Debt Repaid | 2.09% | -136.26% | -128.62% | -2.94% | 77.58% |
| Issuance of Common Stock | -0.91% | -14.46% | 3.05% | -8.32% | 79.32% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -18.81% | -45.47% | -40.55% | 0.37% | 33.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -229.99% | 9,606.25% | 80.56% | 99.93% | 108.94% |